PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
12857432-0	2003	Vanadate regulates the insulin mitogenic effect by modulating SHP-2 association with insulin receptor substrate 1 in JAr human choriocarcinoma cells.	Vanadates	0-8	protein tyrosine phosphatase non-receptor type 11	Homo sapiens	62-67	
12857432-3	2003	When JAr cells were cultured in the presence of 25 mmol/l glucose, treatment with vanadate completely prevented SHP-2 association with IRS1.	Vanadates	82-90	protein tyrosine phosphatase non-receptor type 11	Homo sapiens	112-117	
11342028-4	2001	Binding of LR974P to SHP-2 was inhibited in a dose-dependent fashion by orthovanadate, whereas binding of LY986P was not, indicating that the enzyme binds to these peptides through different sites.	Vanadates	72-85	protein tyrosine phosphatase non-receptor type 11	Homo sapiens	21-26	
17558712-6	2007	Vanadate increases BCR-triggered tyrosine phosphorylation of the cytosolic tyrosine phosphatases, SHP-1 and SHP-2 after 24 hours.	Vanadates	0-8	protein tyrosine phosphatase non-receptor type 11	Homo sapiens	108-113